Waters Corporation (WAT)
|Net Income (ttm)||660.50M|
|Day's Range||361.21 - 363.13|
|52-Week Range||212.85 - 428.22|
|Price Target||358.83 (-0.7%)|
|Est. Earnings Date||Nov 2, 2021|
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry inst... [Read more...]
In 2020, WAT's revenue was $2.37 billion, a decrease of -1.71% compared to the previous year's $2.41 billion. Earnings were $521.57 million, a decrease of -11.93%.Financial Statements
According to 18 analysts, the average rating for WAT stock is "Hold." The 12-month stock price forecast is 358.83, which is a decrease of -0.75% from the latest price.
Waters and University of Delaware Announce Bioprocessing Innovation Partnership, Plan 2022 Opening of Immerse Delawar...
MILFORD, Mass. & NEWARK, Del.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) and the University of Delaware today announced a five-year research partnership to develop new analytical solutions for biop...
Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) will webcast its Q3 2021 financial results conference call live on Tuesday, November 2nd, 2021 at 8:00 a.m. eastern time. Interested invest...
MILFORD, Mass.--(BUSINESS WIRE)---- $WAT #biopharma--Waters announces the appointment of John M. Ballbach to its Board of Directors and the retirement of Dr. Michael J. Berendt from the Waters BoD.
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), PerkinElmer (PKI) and Waters Corporation (WAT) are gaining from strong life science, pharmaceutical and academic end-m...
Waters (WAT) introduces Waters BioAccord System with ACQUITY Premier for seamless monitoring of attributes of biotherapeutics.
Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribu...
MILFORD, Mass.--(BUSINESS WIRE)-- #CQA--The BioAccord System with ACQUITY Premier simplifies CQA monitoring of biologics by improving analyte recovery and assay-to-assay reproducibility.
The Dow Jones dipped about 40 points, and the S&P 500 was flat. Meanwhile, the Nasdaq continued mild gains.
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will present at the Bank of America Global Healthcare Conference 2021 virtually on...
Waters to Participate in a Virtual Fireside Chat at Morgan Stanley's 19th Annual Global Healthcare Conference
MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will participate in a virtual fireside chat at Morgan Stanley's 19th Annual Global...
Does Waters (WAT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Waters (WAT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Waters' (WAT) second-quarter results reflect gains from strong momentum across pharmaceutical, industrial, and governmental and academic markets.
Shares of Waters (NYSE:WAT) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share were up 23.81% over the past year to $2.60, which beat the estimate of $2.24.
MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE: WAT) today announced second quarter 2021 sales of $682 million, a 31% increase as reported, compared to sales of $520 million for the second qu...
Waters' (WAT) second-quarter 2021 results are likely to reflect strength across liquid chromatography instruments and mass spectrometers.
Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) will webcast its Q2 2021 financial results conference call live on Tuesday August 3rd, 2021 at 8:00 a.m. eastern time. To listen to the con...
Waters (WAT) strengthens the product portfolio by introducing TRIOS AutoPilot software for the thermal analyzer product line.
TA Instruments Helps Laboratories Automate Thermal Analysis Workflows with New TRIOS AutoPilot Software
NEW CASTLE, Del.--(BUSINESS WIRE)---- $WAT #thermalanalysis--TRIOS AutoPilot software is now available for the TA Instruments thermal analysis product line.
Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore's Bioprocessing Technolo...
MILFORD, Mass. & SINGAPORE--(BUSINESS WIRE)---- $WAT #bioinformatics--Waters expands collaboration with Singapore's Bioprocessing Technology Institute, A*STAR to accelerate bioprocessing and bioinformat...